Scholar Data
Sign in

A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects

View Dataset
GlaxoSmithKline

Description

This study is a Phase I, open-label, single-sequence drug interaction study to evaluate the effect of repeated doses of GSK1292263 on the pharmacokinetics of rosuvastatin and simvastatin in healthy adult subjects. Each subject will receive single doses of simvastatin and rosuvastatin on two occasions, once alone and once following administration of repeated (BID) doses of GSK1292263.

Citations (0)

Mentions (0)

Metrics

Dataset Index

0.1

FAIR Score

31%

Citations

0

Mentions

0

Metrics Over Time

Publication Details

DOI

10.25934/00000910

Publisher

Vivli

License

Study data may be accessed by completing a request form at https://vivli.org. It will then be reviewed according to the data contributor’s governance policy, see https://vivli.org/members/ourmembers/ for Vivli member’s review process. If approved, use of the data is governed by the data use agreement at https://vivli.org/resources/vivli-data-use-agreement/

Assigned Domain

Subfield

Infectious Diseases

Field

Medicine

Domain

Health Sciences

Confidence Score

40%

Source

Scholar Data Model

Keywords

Conditions: Diabetes Mellitus, Type 2Interventions: SimvastatinInterventions: RosuvastatinInterventions: GSK1292263

Normalization Factors

FT

78.84

CTw

1.00

MTw

1.00